Dr. Judy Ellen Garber M.D.
Hematologist-Oncologist | Hematology & Oncology
44 Binney St Sm 209 Boston MA, 02115About
Dr. Garber received her MD and MPH in 1981 from Yale University School of Medicine. She served her internal medicine residency at Brigham and Women's Hospital, followed by fellowships in hematology at ...
Education and Training
Yale Univ Sch of Med, New Haven Ct 1981
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Internal MedicineAmerican Board of Internal MedicineABIM- 1984
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 1987
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
- Complementary medicine use among women enrolled in a genetic testing program.
- Breast cancer screening: a final analysis?
- One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers.
- Prophylactic oophorectomy and hormone replacement therapy: protection at what price?
- Hereditary cancer predisposition syndromes.
- Accuracy of cancer family histories: comparison of two breast cancer syndromes.
- Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.
- Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon?
- Quality or quantity in the management of hereditary ovarian cancer risk: Is it really a trade-off?
- Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.
- Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.
- Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
- Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
- Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.
Clinical Trials
Awards
- 2011 Boston Super Doctors
- 1997 Charles H. Dyson Scholar in Clinical Research, DFCI
Treatments
- Breast Cancer, Cancer Genetics, Cancer Prevention
Fellowships
- Dana-Farber Cancer Institute, Cancer Epidemiology
- Dana-Farber Cancer Institute, Medical Oncology
- Brigham & Wm's/Dana Farber Can, Fellow- oncology, Hema 1985
Dr. Judy Ellen Garber M.D.'s Practice location
Dr. Judy Ellen Garber M.D.'s reviews
Write ReviewPatient Experience with Dr. Garber
Recommended Articles
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma
Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...
- Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo
In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...
Nearby Providers
- Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114
- Dr. Bruno Bastos M.D.44 Binney St Boston MA 02115
- Dr. Gary M. Strauss M.D.18 Acron Road Brookline Massachusetts 2445
- Dr. Elizabeth Gaughan M.D.330 Brookline Ave Boston MA 02215
- Prabhsimranjot Singh MD17 Faxon St Newton Massachusetts 02458
- Dr. Folefac Edmund M.D.79-81 Highland Ave. Salem MA 01970